- £1.44bn
- £1.60bn
- £257.44m
- 46
- 16
- 91
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 99.3 | 115 | 148 | 200 | 257 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 76.7 | 100 | 113 | 166 | 205 |
Operating Profit | 22.5 | 14.7 | 34.6 | 33.7 | 52.4 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.6 | 11.2 | 27.8 | 35.9 | 24.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.2 | 10.5 | 26.6 | 34.7 | 21.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 17.2 | 10.5 | 26.6 | 34.7 | 21.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17.2 | 10.5 | 26.6 | 34.7 | 21.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.172 | 0.17 | 0.069 | 0.269 | 0.189 |
Dividends per Share |